More than 13 million people worldwide are finding the first success of the coronavirus vaccine. Vaccine mRNA-1273 of the American company Moderna Inc has been a complete success in its first trial. After this, President Donald Trump has expressed happiness by tweeting on Wednesday.
President Trump on Wednesday tweeted – ‘Very good news on vaccines.’ However, Trump did not give more information in his tweet, but it is being speculated that this reaction of Trump has come on the success of Moderna. The first test of Moderna Inc included 45 people who were healthy and aged between 18 and 55 years and the results were successful.
Great News on Vaccines!— Donald J. Trump (@realDonaldTrump) July 15, 2020
Moderna is now preparing for a late-stage trial of the Coronavirus vaccine. According to the company, the trial can be started around July 27. Moderna said that she will conduct a trial of this vaccine at 87 study locations in the US. It is believed that after the third phase of the trial is successful, the company can make a big announcement.
Moderna is trying to make 100 million doses with Catalent Inc by the first quarter of 2020. The packaging, labeling, storage, and distribution of Catalent’s vaccine will take place when Moderna’s vaccine reaches late-stage clinical trials. Catalent has also partnered with Johnson & Johnson and AstraZeneca. Moderna expects its data to arrive in November.
Another good thing about Moderna’s vaccine is that it did not have such a significant side effect, because of which the trial of vaccine should be stopped. If antibodies are produced in initial testing, it is considered a major success, but this does not mean that this vaccine will be effective in eradicating the coronavirus. This first test included 45 such people who were healthy and their age was between 18 and 55 years.
Preparation of late-stage trial of coronavirus vaccine
During this test, the vaccine was also tested on the elderly, whose results have not been reported yet. Legendary drug maker Moderna is now preparing for a late-stage trial of the Coronavirus vaccine. According to the company, the trial can be started around July 27. Moderna said that she will conduct a trial of this vaccine at 87 study locations in the US. It is believed that after the third phase of the trial is successful, the company can make a big announcement.
William Hasseltine, a former Howard researcher, said that the level of an antibody that vaccine has developed is ‘respectable’. It is possible in giving protection against the coronavirus. After giving three doses of vaccine during the trial, half of the people had mild fatigue, body ache, and headache. About 40 percent of people experienced mild fever after giving the vaccine.
The trial will be done in the most corona affected areas
The experimental vaccine will be trialed in 30 other states of the country besides the capital, Washington DC. More than half of the locations selected for vaccine trials are located in Texas, California, Florida, Georgia, Arizona, and North and South Carolina, the most affected by the coronavirus. The US government has also funded Moderna half a million dollars to develop the vaccine. The company claimed to be successful in taking the first two-phase trials of this vaccine. However, the data related to this has not been shared by the company.